# Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone

> **NCT00174200** · NA · COMPLETED · sponsor: **Pfizer** · enrollment: 20 (—)

## Conditions studied

- Schizophrenia
- Psychotic Disorders

## Interventions

- **DRUG:** Risperidone 2 mg

## Key facts

- **NCT ID:** NCT00174200
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-12
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 20 (—)
- **Last updated:** 2008-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00174200

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00174200, "Study To Assess Differential Sensitivity Of 2 Spatial Working Memory Tests In Schizophrenics Treated With Risperidone". Retrieved via AI Analytics 2026-07-06 from https://api.ai-analytics.org/clinical/NCT00174200. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*